SKILJADA
LIVE

Serial Number

79245751

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SKILJADA Trademark

Serial Number: 79245751 • Registration: 5778191

SKILJADA is a trademark filed by NOVARTIS AG on October 5, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 5, 2018

Registration Date

June 18, 2019

Published for Opposition

April 2, 2019

Cancellation Date

August 4, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION PROCESSED BY IB
Dec 21, 2022 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 21, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 21, 2022 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 18, 2019 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Sep 30, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 30, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 18, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2019 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2019 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 19, 2019 PBCR
REFUSAL PROCESSED BY IB
Feb 8, 2019 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2019 CRFA
ASSIGNED TO LIE
Jan 29, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 22, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 22, 2019 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jan 18, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 7, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 31, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 7, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 29, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 22, 2018 REPR